Furthermore, EBV-circRPMS1 has been shown to promote the progression of EBV-associated gastric cancer (EBVaGC) by recruiting Sam68 to the METTL3 promoter, inducing METTL3 expression [87]. Here, METTL3 is linked to gastric cancer.